49 results on '"Carlier H"'
Search Results
2. P720 Exit interviews exploring Crohn’s disease patients’ experience of changes in their bowel urgency during the mirikizumab Phase 3 clinical trial in adult patients with moderate to severe Crohn disease
3. OP05 Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 study
4. Role of Intestinal Hydrolases, Endogenous Substrates, and Chyloportal Partition in Fat Absorption
5. POS0301 STRUCTURAL OUTCOMES IN THE SACROILIAC JOINT AFTER IXEKIZUMAB TREATMENT FOR 16 WEEKS IN PATIENTS WITH ACTIVE NON‑RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY GENDER, HLA-B27, AND BASELINE MRI INFLAMMATION
6. The ASAS-OMERACT core domain set for axial spondyloarthritis
7. Poursuite ou arrêt du traitement par l’ixékizumab chez des patients atteints de spondyloarthrite axiale et ayant atteint la rémission : résultats d’une étude de retrait randomisé, contrôlée versus placebo
8. POS0918 EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS
9. Efficacité et tolérance à 52 semaines de l’ixékizumab dans la spondyloarthrite axiale radiographique chez des patients en réponse inadéquate ou intolérants aux anti-TNF
10. Ixékizumab dans la spondyloarthrite axiale non-radiographique : résultats d’un essai de phase 3
11. 397 Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis
12. THU0440 Ixekizumab Provides Sustained Improvement up To 52 Weeks of Disease Activity as Assessed by Composite Measure Scores in Biologic Disease-Modifying Antirheumatic Drug (bDMARD)-Naive Patients with Active Psoriatic Arthritis
13. OP0109 Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from A Phase 3 Study (Spirit-P1)
14. Transport of Severely Injured Patients
15. Faisabilité de la saisie systématique de données d’exposition dans le dossier médical informatisé en santé au travail (DMST)
16. Partial resection of the scapula and peri-scapular muscles after peri-scapular desmoid fibromatosis. About one case; interest of a rehabilitation program
17. Résection partielle de la scapula et des muscles péri-scapulaires suite à une fibromatose desmoïde péri-scapulaire. À propos d’un cas ; intérêt d’un programme de rééducation
18. SAT0107 Efficacy and Safety After 64 Weeks of Ixekizumab Treatment in a Phase 2 Open Label Extension Study in Patients With Rheumatoid Arthritis
19. Transportation of children: Health vs. medical social
20. Transport d’enfants : sanitaire vs médicosocial
21. Partition of oleic acid between the lymph and portal blood in rats having a diverted bile–pancreatic duct
22. Partition of oleic acid between the lymph and portal blood in rats having a diverted bile-pancreatic duct
23. Expression of fatty acid binding protein in the liver during pregnancy and lactation in the rat
24. Incorporation of Exogenous Unsaturated Fatty Acids in Mouse Jejunal Explants
25. Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate
26. Research of anin vitro model to study the expression of fatty acid-binding proteins in the small intestine
27. Effects in the rat of gestation and lactation on the cytosolic liver fatty acid binding protein (L-FAPc) in the liver
28. Effects in the rat of gestation and lactation on the cytosolic intestinal and liver fatty acid binding proteins (I and L-FABPc) in the small intestine
29. Erucic acid metabolism in rat liver a combined biochemical and radioautographical study
30. Diversion of bile and pancreatic juice and oleic intestinal absorption in the rat
31. Intestinal metabolism of lineoleic acid during its intestinal absorption in the rat
32. Biliary and pancreatic secretions and intestinal acylglycerol acyltransferase activities in the rat
33. Absorption and intestinal catabolism of fatty acids in the rat: effect of chain length and unsaturation
34. Absorption intestinale chez le rat, d'huile de foie de morue, d'huile de menhaden, d'éthyl esters d'acides docosahexaenoïque et eicosapentaenoïque et d'huile de maïs
35. Estérification des acides gras insaturés au cours de l'absorption : étude en culture organotypique d'intestin de souris en fonction de l'âge
36. Absorption sanguine des acides gras chez le rat : influence de la longueur de chaîne et du degré d'insaturation
37. Quantification des ARNm codant pour les fatty acid binding proteins (FABP) entérocytaires par hybridation moléculaire
38. Digestion and absorption of polyunsaturated fatty acids
39. Effect of albumin on oleic acid lymphatic absorption in rats
40. Erucic acid metabolism in rat heart. A combined biochemical and radioautographical study
41. Monensin and14C oleic acid absorption in the rat
42. Effect of monensin and nocodazole on the intestinal lipid esterification in mouse jejunal organ culture
43. Differential intestinal absorption of two fatty acid isomers: elaidic and oleic acids
44. Biochemical and electron microscope radioautographic study of intestinal absorption of tritiated palmitic and oleic acids in control and actidione‐cycloheximide‐treated rats
45. Effect of Various Dietary Fats on the Size and Distribution of Lymph Fat Particles in Rat
46. Influence of the diet on the portal and lymph transport of decanoic acid in rats. Simultaneous study of its mucosal catabolism
47. Electron microscope autoradiographic study of intestinal absorption of decanoic and octanoic acids in the rat.
48. Lipid esterification and secretion by the mouse intestine in organ culture
49. Effect of calcium and magnesium ions on the intestinal absorption of oleic acid in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.